Advances in Biomarkers for Stroke
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: closed (31 January 2022) | Viewed by 4001
Special Issue Editor
Special Issue Information
Dear Colleagues,
Stroke affects 14 million people worldwide every year. It is the third leading global cause of death, and the first cause of physical disability worldwide. Due to the aging of the global population, stroke cases are predicted to increase dramatically in the next decade. In addition, the association between stroke risk and infection with SARS-CoV-2 suggests that stroke incidence could increase even more steeply than currently foreseen.
Tools for risk prediction, early diagnosis, stratification for treatment, and prognosis are fundamental to reduce stroke incidence, facilitate patient management and treatment response, and ultimately improve patient outcome.
Diagnosis of stroke is primarily based on brain imaging, interpretation of patient symptoms, and analysis of clinical information. With stroke presentations ranging from ischemic stroke to hemorrhagic stroke and a plethora of stroke-mimicking conditions, clinicians face a highly challenging diagnostic scenario.
Thanks to the advances in the molecular and pathophysiological understanding of the disease, together with the rise in novel technologies for disease investigation, the use of biomarkers has attracted a great deal of attention in the development of novel approaches to the detection, stratification, and prognosis of stroke patients. This Special Issue will address the current advances in biomarkers for stroke.
Dr. Edoardo Gaude
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
